The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion
Open accessAbstract
BACKGROUND: Malignant pleural effusion affects more than 750,000 persons each year across Europe and the United States. Pleurodesis with the administration of talc in hospitalized patients is the most common treatment, but indwelling pleural catheters placed for drainage offer an ambulatory alternative. We examined whether talc administered through an indwelling pleural catheter was more effective at inducing pleurodesis than the use of an indwelling pleural catheter alone. METHODS: Over a period of 4 years, we recruited patients with malignant pleural effusion at 18 centers in the United Kingdom. After the insertion of an indwelling pleural catheter, patients underwent drainage regularly on an outpatient basis. If there was no evidence of substantial lung entrapment (nonexpandable lung, in which lung expansion and pleural apposition are not possible because of visceral fibrosis or bronchial obstruction) at 10 days, patients were randomly assigned to receive either 4 g of talc slurry or placebo through the indwelling pleural catheter on an outpatient basis. Talc or placebo was administered on a single-blind basis. Follow-up lasted for 70 days. The primary outcome was successful pleurodesis at day 35 after randomization. RESULTS: The target of 154 patients undergoing randomization was reached after 584 patients were approached. At day 35, a total of 30 of 69 patients (43%) in the talc group had successful pleurodesis, as compared with 16 of 70 (23%) in the placebo group (hazard ratio, 2.20; 95% confidence interval, 1.23 to 3.92; P=0.008). No significant between-group differences in effusion size and complexity, number of inpatient days, mortality, or number of adverse events were identified. No significant excess of blockages of the indwelling pleural catheter was noted in the talc group. CONCLUSIONS: Among patients without substantial lung entrapment, the outpatient administration of talc through an indwelling pleural catheter for the treatment of malignant pleural effusion resulted in a significantly higher chance of pleurodesis at 35 days than an indwelling catheter alone, with no deleterious effects. (Funded by Becton Dickinson; EudraCT number, 2012-000599-40 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010
Roberts, M. E., Neville, E., Berrisford, R. G., Antunes, G., Ali, N. J., & on behalf of the BTS Pleural Disease Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.136994 · Cited by 885
Self-citationStrategy for intention to treat analysis in randomised trials with missing outcome data
White, I. R., Horton, N. J., Carpenter, J., statistics, R. I. M. A. S., & Pocock, S. J. (2011) · BMJ · doi:10.1136/bmj.d40 · Cited by 849
Davies, H. E., Mishra, E. K., Kahan, B. C., Wrightson, J. M., Stanton, A. E., Guhan, A., Davies, C. W. H., Grayez, J., Harrison, R., Prasad, A., et al. (2012) · JAMA · doi:10.1001/jama.2012.5535 · Cited by 657
Self-citationTreatment allocation by minimisation
Altman, D. G., & Bland, J. M. (2005) · BMJ · doi:10.1136/bmj.330.7495.843 · Cited by 550
Management of Malignant Pleural Effusions
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.ats8-00 · Cited by 498
Clive, A. O., Kahan, B. C., Hooper, C. E., Bhatnagar, R., Morley, A. J., Zahan-Evans, N., Bintcliffe, O. J., Boshuizen, R. C., Fysh, E. T. H., Tobin, C. L., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205285 · Cited by 446
Self-citationTremblay, A., & Michaud, G. (2006) · Chest · doi:10.1378/chest.129.2.362 · Cited by 349
Improper analysis of trials randomised using stratified blocks or minimisation
Kahan, B. C., & Morris, T. P. (2012) · Statistics in Medicine · doi:10.1002/sim.4431 · Cited by 332
Self-citationKahan, B. C., & Morris, T. P. (2012) · BMJ · doi:10.1136/bmj.e5840 · Cited by 295
Self-citationThomas, R., Fysh, E. T. H., Smith, N. A., Lee, P., Kwan, B. C. H., Yap, E., Horwood, F. C., Piccolo, F., Lam, D. C. L., Garske, L. A., et al. (2017) · JAMA · doi:10.1001/jama.2017.17426 · Cited by 289
Self-citationVan Meter, M. E. M., McKee, K. Y., & Kohlwes, R. J. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1472-0 · Cited by 287
Wahidi, M. M., Reddy, C., Yarmus, L., Feller-Kopman, D., Musani, A., Shepherd, R. W., Lee, H., Bechara, R., Lamb, C., Shofer, S., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201607-1404oc · Cited by 269
Interventions for the management of malignant pleural effusions: a network meta-analysis
Clive, A. O., Jones, H. E., Bhatnagar, R., Preston, N. J., & Maskell, N. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010529.pub2 · Cited by 228
Self-citationZimmer, P. W., Hill, M., Casey, K. R., Harvey, E. M., & Low, D. E. (1997) · CHEST Journal · doi:10.1378/chest.112.2.430 · Cited by 145
Optimal Management of Malignant Pleural Effusions (Results of CALGB 30102)
Demmy, T. L., Gu, L., Burkhalter, J. E., Toloza, E. M., D’Amico, T. A., Sutherland, S., Wang, X., Archer, L. E., Veit, L. J., Kohman, L. J., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0102 · Cited by 108
Warren, W., KIM, A., & LIPTAY, M. (2007) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2007.10.002 · Cited by 90
Cost‐effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion
Olfert, J., Penz, E. D., Manns, B., Mishra, E. K., Davies, H. E., Miller, R. F., Luengo-Fernández, R., Gao, S., & Rahman, N. M. (2016) · Respirology · doi:10.1111/resp.12962 · Cited by 69
Self-citationTalc Pleurodesis Through Indwelling Pleural Catheters for Malignant Pleural Effusions
Ahmed, L., Ip, H., Rao, D., Patel, N., & Noorzad, F. (2014) · CHEST Journal · doi:10.1378/chest.14-0394 · Cited by 46
Self-citation
Cited by
Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline
Feller-Kopman, D. J., Reddy, C. B., DeCamp, M. M., Diekemper, R. L., Gould, M. K., Henry, T., Iyer, N. P., Lee, Y. C. G., Lewis, S. Z., Maskell, N. A., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1415st · Cited by 470
Self-citationUpdate on biology and management of mesothelioma
Asciak, R., George, V., & Rahman, N. M. (2021) · European Respiratory Review · doi:10.1183/16000617.0226-2020 · Cited by 75
Self-citation
Metadata
- Authors
- Bhatnagar, R., Keenan, E. K., Morley, A. J., Kahan, B. C., Stanton, A. E., Haris, M., Harrison, R. N., Mustafa, R. A., Bishop, L. J., Ahmed, L., West, A., Holme, J., Evison, M., Munavvar, M., Sivasothy, P., Herre, J., Cooper, D., Roberts, M., Guhan, A., Hooper, C., Walters, J., Saba, T. S., Chakrabarti, B., Gunatilake, S., Psallidas, I., Walker, S. P., Bibby, A. C., Smith, S., Stadon, L. J., Zahan-Evans, N. J., Lee, Y. C. G., Harvey, J. E., Rahman, N. M., Miller, R. F., & Maskell, N. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-04-05
- Volume
- 378
- Issue
- 14
- Pages
- 1313-1322
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2795716722
- Cited by
- 279
- References
- 22
- FWCI
- 22.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.